MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Acute administration of methylphenidate modulates functional connectivity during the processing of irrelevant stimuli in Parkinson’s disease patients

    N. Fogelson, L. Li, B. Tan, E. Martinez Lopez, M. Roson Gonzalez, M. Fernandez Delolmo, T. Gurevich, L. Vela Desojo (Fuenlabrada, Spain)

    Objective: Examine the effects of a single dose of methylphenidate (MPD), on event-related functional connectivity (FC), in patients with Parkinson’s disease (PD). Background: Recent studies…
  • 2026 International Congress

    Sleep Circadian Rhythms and Brain Disorders: A Large Prospective Cohort and Mendelian randomization Study

    L. Li, Z. Zhong, L. Liu (shanghai, China)

    Objective: This study aims to investigate the causal relationship between disruptions in sleep circadian rhythms and the risk of seven brain disorders. Background: Disruptions in…
  • 2026 International Congress

    Dietary and Environmental Risk Factors of Parkinson’s Disease: An Integrated Network Pharmacology Approach

    D. Ghosh, P. Basu, S. Mondal, S. Dey, S. Pal (Kolkata, India)

    Objective: To investigate dietary and environmental determinants of Parkinson’s disease (PD) and related mortality by integrating large-scale clinical phenotyping with network pharmacology and molecular docking…
  • 2026 International Congress

    A Longitudinal Case of Adult-Onset Progressive Ataxia in a Patient with a Pathogenic Variant of IRF2BPL

    S. de Groot, W. Rai (Sioux Falls, USA)

    Objective: To describe the course of a patient with an inherited IRF2BPL variant presenting as adult-onset indolent ataxia and tremor with no prior developmental abnormalities,…
  • 2026 International Congress

    The GLP-1 Agonist Paradox in Parkinson’s Disease: A Comparative Analysis of Lixisenatide and Exenatide Phase III Trial Outcomes and Neuroprotective Mechanisms

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To assess the pharmacological and methodological factors underlying the "GLP-1 paradox" by comparing the outcomes of lixisenatide and exenatide, with an emphasis on kinetics,…
  • 2026 International Congress

    Beyond Parkinson’s Disease, Impulse Control Dysregulation: The Psychosocial Correlates of Problematic Internet Use

    T. Adeoye, O. Buhari, O. Adeoye (Ogbomoso, Nigeria)

    Objective: To determine the prevalence of problematic internet use and associated psychosocial correlates as a phenotype of impulse control dysregulation among undergraduates. Background: Impulse control…
  • 2026 International Congress

    One day accelerated 10 Hz rTMS for Focal Hand Dystonia: A Phase II Clinical Trial

    I. Xu, Z. Simsek, P. Mulcahey, C. Bui, Y. Li, N. Hamzah, A. Norain, M. Lipp, D. Bitlis, S. Dave, K. Grozev, C. Russell, C. Petty, M. Lutz, A. Peterchev, N. Bukhari-Parlakturk (Durham, USA)

    Objective: To evaluate the efficacy of four sessions of 10 Hz repetitive transcranial magnetic stimulation delivered in one day (rTMS) to patients with focal hand…
  • 2026 International Congress

    Cognitive Progression in Elderly Essential Tremor Patients: Evidence from an 18-Month Prospective Cohort

    E. Abed (Cairo, Egypt)

    Objective: Essential tremor (ET) is one of the most prevalent neurological disorders and has increasingly been linked to cognitive dysfunction. However, most existing data regarding…
  • 2026 International Congress

    Micro- and Nanoplastics in Parkinson’s Disease Pathogenesis An Emerging Environmental Risk Factor

    A. Aralbayeva, Z. Akhmetzhanova, A. Baidarbekova (Astana, Kazakhstan)

    Objective: To synthesize current experimental and translational evidence supporting the hypothesis that micro- and nanoplastics (MNPs) may contribute to Parkinson’s disease (PD) pathogenesis through neuroinflammatory…
  • 2026 International Congress

    Proposal of Anatomo-Functional Tremor Patterns for Ultrasound-Guided Botulinum Toxin Infiltration

    G. Salazar, I. Caballero (Terrassa, Spain)

    Objective: To propose a practical anatomo-functional framework for ultrasound-guided BoNT-A infiltration in upper limb tremor based on tremor biomechanics. Background: Botulinum toxin type A (BoNT-A)…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley